一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Neuropharmacology >>article
Neuropharmacology

Neuropharmacology

IF: 4.6
Download PDF

Ketamine, benzoate, and sarcosine for treating depression

Published:1 February 2023 DOI: 10.1016/j.neuropharm.2022.109351 PMID: 36423705
Yu-Jung Cheng , Chieh-Hsin Lin , Hsien-Yuan Lane

Abstract

Studies have demonstrated the beneficial therapeutic effects of sarcosine, benzoate, and ketamine (including esketamine and arketamine) on depression. These drugs mainly act by modulating N-methyl-d-aspartate glutamate receptors (NMDARs) and reducing inflammation in the brain. Although ketamine, benzoate, and sarcosine act differently as the antagonists or coagonists of NMDARs, they all have demonstrated efficacy in animal models or human trials. In vitro and in vivo studies have indicated that sarcosine, benzoate, and ketamine exert their anti-inflammatory effects by inhibiting microglial activity. This review summarizes and compares the efficacy of the possible therapeutic mechanisms of sarcosine, benzoate, ketamine, esketamine, and arketamine. These compounds act as both NMDAR modulators and anti-inflammatory drugs and thus can be effective in the treatment of depression.

This article is part of the Special Issue on 'Ketamine and its Metabolites'.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Sarcosine 107-97-1 C3H7NO2 763 suppliers $5.00-$2890.00
Denatonium Benzoate 3734-33-6 C28H34N2O3 589 suppliers $7.00-$1500.00

Similar articles

合肥市| 隆昌县| 浑源县| 华池县| 海安县| 崇阳县| 宿松县| 上蔡县| 普格县| 武夷山市| 安宁市| 遂溪县| 屏边| 朝阳区| 沾化县| 丰原市| 临江市| 丰城市| 蒲城县| 哈尔滨市| 彭山县| 陆河县| 玉树县| 石景山区| 上思县| 清徐县| 枣阳市| 建昌县| 九寨沟县| 河源市| 云霄县| 静乐县| 靖边县| 天柱县| 册亨县| 怀宁县| 萨迦县| 岗巴县| 广丰县| 元谋县| 绍兴市|